Australia investigates possible link of blood clot case to AstraZeneca vaccine

NETHERLANDS-HEALTH-VIRUS-VACCINE

It said it wasn't clear if the shots are causing the clots, and that its "rigorous review into the United Kingdom reports of rare and specific types of blood clots is ongoing".

The head of the European Medicines Agency (EMA) has said that there is "no evidence" to support restricting the use of the AstraZeneca vaccine in any population.

In a statement, the government said there had been five reports of thrombosis and abnormally low platelets, which help blood clot, in women aged 25 to 65 (around 400,000 AstraZeneca injections have been given in the Netherlands, according to the same government statement).

The Netherlands was the lastest European countries to stop using the AstraZeneca vaccine to vaccinate people under the age of 60, amid fears of a link between it and the incidence of rare blood clots.

British regulators said they have identified 30 cases of rare blood clot events associated with the AstraZeneca vaccine but stressed the benefits of the jab in preventing coronavirus outweigh any risks.

The majority of people who have had the rare cerebral venous sinus thrombosis (CVST) blood clot both here and and in Europe are younger females, she said, adding: "But - and this is a really important but - younger females are already at higher risk of having this type of clot whether they've had the vaccine or not".


The vaccine was developed with the University of Oxford in Britain. It has said a causal link between unusual blood clots in people who have had the vaccine is "not proven, but is possible", and that the benefits of the vaccine outweigh the risks of side effects. It previously declared the AstraZeneca vaccine safe, just as the World Health Organization did.

"Receiving the vaccine is by far the safest choice in terms of minimizing individual risk of serious illness or death", he said.

"That's still up in the air", said Fauci when asked whether the US will use the AstraZeneca vaccine doses.

Germany took a similar decision earlier this week.

Australia is investigating whether a blood clotting case recorded on Friday is related to the AstraZeneca coronavirus vaccine, a health official said, raising concern in a nation where most people are expected to receive the drugmaker's shot. Meanwhile, Australia on Saturday said it would continue to use the vaccine after one case that highlighted concern over blood clots. It also ordered 30 million doses of the Pfizer-BioNTech vaccine the same year.

Related:

Comments

Latest news

Police officer killed in vehicle attack on US Capitol
But Washington Metropolitan Police Chief Robert Contee indicated that a terror link was not suspected at this stage. Senate and House of Representatives were not in session Friday. "Another tragic day at the Capitol ", tweeted Rep.

Statement from Warden Bob Crate on provincial shutdown — RELEASE
Under the province's new shutdown rules, all indoor organized events and social gatherings are prohibited. The previous peak of 420 came in mid-January, during the height of the second wave of the pandemic.

Australia investigates possible link of blood clot case to vaccine
The provincial government said Thursday that it is lowering the age of those who can book a shot at a pharmacy to 55. More people in Ontario will soon be able to book a shot to get a COVID-19 vaccine at a pharmacy.

US Capitol complex on lockdown after reports motorist rams officers
The law enforcement officials told the AP that the suspect was shot and was being taken to the hospital in critical condition. Authorities said that there was no longer an ongoing threat and that the attack did not appear to be related to terrorism.

Police officer, suspect dead after car rams into U.S. Capitol barricade
The US Capitol complex was placed on lockdown after the shooting and staff were told they could not enter or exit buildings. Since then security officials have said there is an ongoing threat from extreme-right groups and some Trump supporters.

Other news